Symrise stock faces CFO transition as Martin Huber takes over in 2027
Published on 11/11/2026 at 11:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership plan adds continuity
- Olaf Klinger will oversee an orderly handover before leaving Symrise's executive board.
- Martin Huber brings international finance and transformation experience to the group.
- Walter Ribeiro's extended mandate supports continuity in Taste, Nutrition & Health.
Symrise announced on Tuesday, November 10, that Martin Huber will become its next chief financial officer on April 1, 2027. The Supervisory Board also extended Walter Ribeiro's Executive Board mandate as President Taste, Nutrition & Health through September 19, 2031. The company published the announcement in its official release.
Planned finance leadership transition
Huber, 56, will succeed Olaf Klinger, 61, who will leave the Executive Board after more than eleven years as CFO. Klinger will remain in the role until March 31, 2027, allowing the company to prepare an orderly handover.
Symrise said Huber brings more than 20 years of international finance and leadership experience from Nestle, Nespresso and Aryzta. At Aryzta, he helped lead an operational and financial transformation, with a focus on profitability, cash flow and return on capital.
Huber said he intends to support the continued execution of the ONE SYM transformation, disciplined capital allocation and long-term profitable growth. The appointment therefore sets a defined succession timetable while keeping the existing CFO in place through the end of March.
Continuity across a core division
Ribeiro has served on Symrise's Executive Board since September 2024 and has worked for the company for more than 30 years. His extended mandate keeps leadership continuity in Taste, Nutrition & Health, a business area that the company says benefits from his industry expertise, international experience and knowledge of the value chain.
The personnel decisions add a governance focus to Symrise's recent operating agenda. On October 28, the company reported strong, volume-led organic sales growth for the third quarter and confirmed its full-year outlook, according to the investor information page. The CFO transition now gives investors a future management milestone to follow alongside execution of that outlook.
Share price remains near recent range
Symrise stock traded at 93.92 euros on Xetra at 12:12 CET on Wednesday, November 11, 0.04 percent below the Xetra close of 93.96 euros on Tuesday. The quotation was 64.70 euros to 102.85 euros over the preceding 52 weeks. The move should be read as a market snapshot rather than as a proven reaction to the management announcement.
Symrise AG at a glance
- Company: Symrise AG
- ISIN: DE000SYM9999
- Ticker: SY1
- Trading venue: Xetra
- Price: 93.92 euros at 12:12 CET on November 11, 2026
- Change: 0.04 percent below the Xetra close of November 10, 2026
- 52-week range: 64.70 to 102.85 euros
- Market capitalization: 12.884 billion euros
The German equity market remains the relevant backdrop for Symrise, while Current market reports provide broader trading context.
Investors will next watch the handover process, the incoming CFO's priorities and Symrise's progress under the confirmed operating outlook. More news and analyses on Symrise stock.
